BiotechTube
Home/Orbus Therapeutics/Jennifer Ekelund
JE

Jennifer Ekelund

Head, Regulatory Affairs and Quality Assurance

Orbus Therapeutics

Therapeutic Areas

OncologyRare Diseases

Orbus Therapeutics Pipeline

DrugIndicationPhase
EflornithineAnaplastic Astrocytoma (AA3 / Grade 3 Glioma)Phase 3

Leadership Team at Orbus Therapeutics

JL
Jason Levin
Founder, Director and Chief Executive Officer
JW
Jackie Walling, MBChB, PhD
Chief Medical Officer (Consultant)
NY
Noymi Yam, PhD
Vice President, Chief Scientific Officer
View full Orbus Therapeutics profile